Healthcare -
Biotechnology - NASDAQ - BM
$ 26.81
-3.02 %
$ 1.96 B
Market Cap
-112.25
P/E
KNSA - REVENUE
Revenue KNSA - Kiniksa Pharmaceuticals, Ltd.
423 M
LAST VALUE
38.64%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR